Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-10-9
pubmed:abstractText
Exendin-4 (Ex4) is a peptide found in the lizard Heloderma suspectum, and it has a high similarity to glucagon-like peptide 1 (GLP-1). It induces insulin secretion without the risk of hypoglycemic episodes. Cyclin-dependent kinase 5 (Cdk5) is a serine/threonine kinase that is predominantly expressed in neurons. Recent studies have shown that this kinase regulates glucose-stimulated insulin secretion. Cdk5 inhibition enhances insulin secretion under conditions of stimulation by high glucose, but not low glucose. In the present study, we examined whether R-roscovitine (R-ros), a Cdk5 inhibitor, enhances insulin secretion induced by Ex4. R-ros induced Ex4-dependent insulin secretion under conditions of high glucose, but not low glucose in MIN6B1 cells. The enhancement by R-ros was also observed in db/db mice, a mouse model of type 2 diabetes. Moreover, long-term treatment with Ex4 and R-ros significantly improved HbA1c compared with treatment using only Ex4. These results suggest that a co-application of R-ros and Ex4 may become a promising therapy for the treatment of type 2 diabetes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Cdk5 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Cyclin-Dependent Kinase 5, http://linkedlifedata.com/resource/pubmed/chemical/Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated, http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Insulin, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Purines, http://linkedlifedata.com/resource/pubmed/chemical/Venoms, http://linkedlifedata.com/resource/pubmed/chemical/exenatide, http://linkedlifedata.com/resource/pubmed/chemical/roscovitine
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1880-6546
pubmed:author
pubmed:issnType
Print
pubmed:volume
57
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
235-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17854513-Age Factors, pubmed-meshheading:17854513-Animals, pubmed-meshheading:17854513-Blood Glucose, pubmed-meshheading:17854513-Cell Line, pubmed-meshheading:17854513-Cyclin-Dependent Kinase 5, pubmed-meshheading:17854513-Dose-Response Relationship, Drug, pubmed-meshheading:17854513-Glucose, pubmed-meshheading:17854513-Glucose Tolerance Test, pubmed-meshheading:17854513-Hemoglobin A, Glycosylated, pubmed-meshheading:17854513-Hypoglycemic Agents, pubmed-meshheading:17854513-Insulin, pubmed-meshheading:17854513-Insulin-Secreting Cells, pubmed-meshheading:17854513-Male, pubmed-meshheading:17854513-Mice, pubmed-meshheading:17854513-Mice, Obese, pubmed-meshheading:17854513-Peptides, pubmed-meshheading:17854513-Protein Kinase Inhibitors, pubmed-meshheading:17854513-Purines, pubmed-meshheading:17854513-Venoms
pubmed:year
2007
pubmed:articleTitle
A Cdk5 inhibitor enhances the induction of insulin secretion by exendin-4 both in vitro and in vivo.
pubmed:affiliation
Department of Physiology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, 700-8558 Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't